ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schols, A.M.W.J.
Right arrow Articles by Wouters, E.F.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schols, A.M.W.J.
Right arrow Articles by Wouters, E.F.M.
Eur Respir J 2001; 17:337-342
Copyright ©ERS Journals Ltd 2001


Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids

A.M.W.J. Schols1, G. Wesseling1, A.D.M. Kester2, G. de Vries1, R. Mostert3, J. Slangen4 and E.F.M. Wouters1

Depts of 1 Pulmonology and 2 Methodology and Statistics and 3 Epidemiology, Maastricht University, Maastrich and 4 Asthma Centre Hornerheide, Horn, the Netherlands

CORRESPONDENCE: A.M.W.J. Schols, Dept of Pulmonology, University Hospital Maastricht, P.O. Box 5800, 6202 AZ, Maastricht. Fax: 31 433875051

Keywords: chronic obstructive pulmonary disease, corticosteroids, survival, systemic administration

Received: February 16, 2000
Accepted October 24, 2000

Systemic corticosteroids are often administered in COPD patients. The relationship between systemic glucocorticoids and mortality in patients with moderate to severe chronic obstructive pulmonary disease (COPD) was retrospectively analysed. Baseline characteristics of the patients, in stable clinical condition, were collected on admission to a pulmonary rehabilitation centre. Overall mortality was asessed at the end of follow-up. The Cox proportional hazards model was used to quantify the relationship between glucocorticoid use, distinguishing administration route (oral/inhalation) and oral dose, and overall mortality, adjusted for the influence of age, sex, smoking, lung function, resting arterial blood gases and body mass index.

On multivariate analysis, oral glucocorticoid use at a (prednisone equivalent) dose of 10 mg·day–1 without inhaled glucocorticoids, was associated with an increased risk (RR=2.34, 95% confidence interval (CI) 1.24–4.44) while 15 mg·day–1 carried a relative risk of 4.03, CI=1.99–8.15). A significant interaction was observed between inhaled and oral glucocorticoid use. Combined with inhaled glucocorticoids, the relative risk of oral glucocorticoid use appeared to be significantly smaller.

It is concluded that in severe chronic obstructive pulmonary disease, maintenance treatment with oral glucocorticoids is associated with increased mortality in a dose-dependent manner. Since the present study design cannot exclude the possibility of bias by indication, further prospective studies are indicated using a broader patient characterization.




This article has been cited by other articles:


Home page
ERRHome page
N. Roche
Where current pharmacological therapies fall short in COPD: symptom control is not enough
Eur. Respir. Rev., September 1, 2007; 16(105): 98 - 104.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D D Sin
Inhaled corticosteroids and mortality in COPD.
Thorax, October 1, 2006; 61(10): 918 - 918.
[Full Text] [PDF]


Home page
ChestHome page
W. Matsuyama, H. Mitsuyama, M. Watanabe, K.-i. Oonakahara, I. Higashimoto, M. Osame, and K. Arimura
Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD
Chest, December 1, 2005; 128(6): 3817 - 3827.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38.
[Full Text] [PDF]


Home page
ChestHome page
N. J. M. Cano, C. Pichard, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J.-P. Laaban, J.-C. Melchior, J.-C. Raphael, et al.
C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure
Chest, August 1, 2004; 126(2): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
T J Ringbaekl, K Viskuml, and P Lange
BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy
Chronic Respiratory Disease, April 1, 2004; 1(2): 71 - 78.
[Abstract] [PDF]


Home page
Chronic Respiratory DiseaseHome page
E. C Creutzberg
Factors associated with prognosis in COPD: influence of body composition and systemic corticosteroid use on morbidity and mortality
Chronic Respiratory Disease, April 1, 2004; 1(2): 79 - 81.
[PDF]


Home page
Eur Respir JHome page
The pharmacoepidemiology of COPD: Recent advances and methodological discussion
Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s.
[Full Text] [PDF]


Home page
ChestHome page
K. H. Groenewegen, A. M.W.J. Schols, and E. F.M. Wouters
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Chest, August 1, 2003; 124(2): 459 - 467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist
Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D.D. Sin and S.F.P. Man
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Eur. Respir. J., February 1, 2003; 21(2): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.B. Soriano, J. Vestbo, N.B. Pride, V. Kiri, C. Maden, and W.C. Maier
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
Eur. Respir. J., October 1, 2002; 20(4): 819 - 825.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.J.M. Cano, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J-P. Laaban, J-C. Melchior, C. Pichard, J-C. Raphael, et al.
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation
Eur. Respir. J., July 1, 2002; 20(1): 30 - 37.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.